12.01.2011 - Eli Lilly struck a drug-development alliance with Germany's Boehringer Ingelheim as the U.S drugmaker tries to revive its diabetes business after setbacks and help it maneuver past...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)